These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 21166558
1. The pharmaceutical pipeline for atrial fibrillation. Santangeli P, Di Biase L, Pelargonio G, Burkhardt JD, Natale A. Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558 [Abstract] [Full Text] [Related]
2. New antiarrhythmic drugs for treatment of atrial fibrillation. Dobrev D, Nattel S. Lancet; 2010 Apr 03; 375(9721):1212-23. PubMed ID: 20334907 [Abstract] [Full Text] [Related]
3. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm]. Hirt MN, Eschenhagen T. Dtsch Med Wochenschr; 2010 May 03; 135(19):971-6. PubMed ID: 20446233 [Abstract] [Full Text] [Related]
4. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations. Singh BN. J Cardiovasc Pharmacol Ther; 2010 Dec 03; 15(4 Suppl):31S-5S. PubMed ID: 21098417 [Abstract] [Full Text] [Related]
5. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant. Camm AJ, Savelieva I. J Interv Card Electrophysiol; 2008 Oct 03; 23(1):7-14. PubMed ID: 18523740 [Abstract] [Full Text] [Related]
6. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope? Ehrlich JR, Nattel S. Curr Opin Cardiol; 2009 Jan 03; 24(1):50-5. PubMed ID: 19077816 [Abstract] [Full Text] [Related]
7. Dronedarone: an emerging therapy for atrial fibrillation. Rosei EA, Salvetti M. Ther Adv Cardiovasc Dis; 2010 Jun 03; 4(3):155-64. PubMed ID: 20418270 [Abstract] [Full Text] [Related]
8. Advances in the treatment of atrial fibrillation. Miranda RI, Simpson CS, Michael KA, Abdollah H, Baranchuk AM, Redfearn DP. Minerva Cardioangiol; 2010 Dec 03; 58(6):637-48. PubMed ID: 21135805 [Abstract] [Full Text] [Related]
9. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone. Krishnamoorthy S, Lip GY. Expert Rev Cardiovasc Ther; 2009 May 03; 7(5):473-81. PubMed ID: 19419255 [Abstract] [Full Text] [Related]
11. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation]. Hinneburg I. Med Monatsschr Pharm; 2011 May 03; 34(5):154-8. PubMed ID: 21644373 [Abstract] [Full Text] [Related]
12. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee. Can J Cardiol; 2011 May 03; 27(1):47-59. PubMed ID: 21329862 [Abstract] [Full Text] [Related]
15. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH, Atrial Arrhythmia Conversion Trial (ACT-III) Investigators. Am J Cardiol; 2010 Nov 01; 106(9):1277-83. PubMed ID: 21029824 [Abstract] [Full Text] [Related]
16. New anthyarrhythmic drugs for atrial fibrillation. Matassini MV, Guerra F, Scappini L, Urbinati A, Capucci A. Future Cardiol; 2015 Nov 01; 11(6):705-17. PubMed ID: 26631497 [Abstract] [Full Text] [Related]
17. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Dale KM, White CM. Ann Pharmacother; 2007 Apr 01; 41(4):599-605. PubMed ID: 17389667 [Abstract] [Full Text] [Related]
18. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Europace; 2011 Mar 01; 13(3):308-28. PubMed ID: 21345926 [Abstract] [Full Text] [Related]
20. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation. Garcia D, Cheng-Lai A. Cardiol Rev; 2009 Mar 01; 17(5):230-4. PubMed ID: 19690474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]